Si-Bone (SIBN) Receivables - Other (2021 - 2022)
Si-Bone (SIBN) posted Receivables - Other of $200000.0 for Q4 2022, down 33.33% on a QoQ basis from $300000.0 in Q4 2021, and down 33.33% year-over-year from $300000.0 in Q4 2021.
Powered by 
Analysis
Si-Bone (SIBN) Receivables - Other (2021 - 2022) Analysis & Trends
Si-Bone has reported Receivables - Other for 2 years, with the latest figure at $200000.0 in Q4 2022.
- On a quarterly basis, Receivables - Other fell 33.33% year-over-year to $200000.0 in Q4 2022; TTM through Dec 2022 was $200000.0, a 33.33% decrease from a year earlier, with the FY2022 full-year figure at $200000.0, down 33.33% from the prior year.
- Receivables - Other was $200000.0 for Q4 2022 at Si-Bone, down from $300000.0 in the prior quarter.
- The five-year high for Receivables - Other was $300000.0 in Q4 2021, with the low at $200000.0 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Si-Bone | 818.82 Mn | 672.88 Mn | 44.55 Mn |